Revised essential drugs list on Indian agenda amid tensions
This article was originally published in Scrip
Executive Summary
The pharmaceutical industry's virtual no-show at a recent key consultative session called by India's apex drug pricing authority has highlighted the heightened ongoing tensions in the sector.